Date published: 2026-5-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

CaMKIV Inhibitors

CaMKIV inhibitors belong to a distinctive chemical class of compounds that hold significant importance in the field of cellular signaling and molecular pharmacology. CaMKIV, or Calcium/Calmodulin-dependent protein kinase IV, is a serine/threonine protein kinase that plays a pivotal role in various cellular processes, including gene transcription, cell cycle regulation, and neuronal signaling. CaMKIV is a part of the CaMK family, which responds to changes in intracellular calcium levels by activating downstream signaling cascades. The development of CaMKIV inhibitors stems from the recognition of its involvement in vital physiological pathways and the to modulate these pathways for various purposes. Structurally, CaMKIV inhibitors are designed to specifically target the active site of the kinase enzyme, where ATP and substrates bind for catalysis. These inhibitors are characterized by their distinct chemical scaffolds, often involving heterocyclic moieties and functional groups that establish interactions with key amino acid residues within the active site pocket of CaMKIV. The design of these compounds takes into account factors such as binding affinity, selectivity, and pharmacokinetic properties to ensure their potency and effectiveness in modulating CaMKIV activity.

Researchers employ various strategies for the synthesis and optimization of CaMKIV inhibitors, often involving computational methods, structure-based drug design, and high-throughput screening techniques. The ultimate goal is to develop compounds that can selectively inhibit CaMKIV without affecting other closely related kinases or causing off-target effects. The discovery and development of CaMKIV inhibitors contribute to our understanding of cellular signaling mechanisms and provide valuable tools for studying the intricate pathways in which CaMKIV is involved. By elucidating the specific roles of CaMKIV in these processes, researchers can gain insights into applications for these inhibitors beyond the scope of this description.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

KN-93

139298-40-1sc-202199
1 mg
$182.00
25
(1)

KN-93 is a well-known cell-permeable inhibitor of CAMKIV. It belongs to the class of synthetic compounds called bisindolylmaleimides. It competitively inhibits CAMKIV by blocking the calmodulin-binding domain, thereby preventing the enzyme's activation.

STO-609

52029-86-4sc-507444
5 mg
$140.00
(0)

STO-609 is a selective inhibitor of CAMKIV that works by targeting the calmodulin-binding site. It has been widely used in research to study the functions of CAMKIV and its downstream signaling pathways.

Cdk9 Inhibitor II

140651-18-9sc-203326
5 mg
$172.00
1
(1)

CAMKIIN (CAMKIV Inhibitory Peptide) is a peptide-based inhibitor that mimics the autoinhibitory domain of CAMKIV. It competes with the native autoinhibitory domain, effectively preventing CAMKIV activation.